The severity of BF.7 variant of coronavirus in India may not be as serious as it is currently prevailing in China as Indian have already developed 'herd immunity' a top official of CSIR- Centre for......
Allaying fears about BF.7 variant of coronavirus, a prominent scientist on Friday said it is a sub-variant of Omicron strain and that India need not worry too much about its severity on the......
Covishield and Covaxin -- the two coronavirus vaccines currently in use in India -- have efficacy against the 'Indian strain' and show "milder" illness in case of infection post vaccination, a......
Renowned scientist Pushpa Mitra Bhargava, the founder director of CSIR-Centre for Cellular Molecular Biology in Hyderabad, who returned his Padma Bhushan award two years ago in protest against the......
There are at least seven major variants of coronavirus, including B.1.617 and B.1.351 (Beta), in Varanasi and its adjoining areas, according to a study conducted by the Banaras Hindu University and......
P M Bhargava, founder director of Centre for Cellular and Molecular Biology and chairman of The March, a city-based non-governmental organisation, has suggested the Centre to ban multi-national......
Indian scientists as well as biotech firms have awakened to the fact that there is a genetic jackpot in the country's endogamous gene pool. If the genetic study of 275,000 pure-bred residents of......
The company has been developing donor-derived stem cell platforms for regenerative medicine and drug discovery applications. Image: Subhadra Dravida, founder, Transcell Biologics. ......
The annual award includes a pure gold medal, a citation and a prize purse worth $ 100,000 or its equivalent in the Indian rupees. IMAGE: Addressing an event organised to announce the winners of......
Indian scientists who wrote to the PM last week are not entirely rejecting GMOs but instead asking for caution and further testing to establish their safety, writes Rajni Bakshi. When dignitaries......